These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11091175)

  • 21. [Changes of alpha hANP concentration in arterial and coronary sinus blood during and after cardiopulmonary bypass].
    Nakahara H
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):537-46. PubMed ID: 8515151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preexisting cardiopulmonary disease attenuating the atrial natriuretic peptide response. Results in patients with acute respiratory failure.
    Westendorp RG; Roos AN; Walma ST; Frölich M; Meinders AE
    Chest; 1992 Dec; 102(6):1758-63. PubMed ID: 1332838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
    Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
    Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
    Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
    Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
    Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
    J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal short-term renal response to acute volume expansion in heart transplant recipients: a role for atrial natriuretic peptide?
    Geny B; Charloux A; Schaefer A; Brandt C; Charpentier A; Kretz JG; Eisenmann B; Haberey P; Piquard F
    J Heart Lung Transplant; 1998 Nov; 17(11):1081-8. PubMed ID: 9855447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levels of plasma endothelin, nitric oxide and atrial natriuretic peptide after cardiopulmonary bypass and influence of inhaled nitric oxide in patients with ventricular septal defect and pulmonary hypertension].
    Jiang H; Zhang R; Gong H; Ma Z; Li X; Song H
    Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):290-3. PubMed ID: 12133363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
    Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
    Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma ANP and cyclic GMP levels versus left ventricular performance at different AV delays in AV sequential pacing.
    Surdacki A; Bednarek J; Radziszewski W; Szczepkowski J; Dubiel JS; Ruskoaho H; Sedziwy L; Wieczorek E
    Pacing Clin Electrophysiol; 1994 Apr; 17(4 Pt 1):627-36. PubMed ID: 7516546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.
    Geny B; Hardy H; Lonsdorfer J; Eisenmann B; Haberey P; Piquard F
    Hypertension; 1999 Apr; 33(4):969-74. PubMed ID: 10205232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide plasma levels during cardiac surgery.
    Flezzani P; McIntyre RW; Xuan YT; Su YF; Leslie JB; Watkins WD
    J Cardiothorac Anesth; 1988 Jun; 2(3):274-80. PubMed ID: 17171860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure.
    Tsutamoto T; Kanamori T; Wada A; Miyauchi N; Murata T; Kinoshita M
    Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial natriuretic peptide, cyclic guanosine monophosphate and sodium excretion during postnatal adaptation in male infants below 34 weeks gestation with severe respiratory distress syndrome.
    Midgley J; Modi N; Littleton P; Carter N; Royston P; Smith A
    Early Hum Dev; 1992 Feb; 28(2):145-54. PubMed ID: 1316834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading.
    Weil J; Lang RE; Suttmann H; Rampf U; Bidlingmaier F; Gerzer R
    Klin Wochenschr; 1985 Dec; 63(24):1265-8. PubMed ID: 3003451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.